Ibandronate Sodium

CAS 138844-81-2 12 current records 2 historicalSmall Molecule

Who holds supplier records for Ibandronate Sodium? 12 organisations hold a current record for Ibandronate Sodium: an active US FDA Type II Drug Master File or a CEP. A further 2 organisations have only historical (inactive) DMF filings. 3 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (8), Canada (1), Poland (1) and Argentina (1); not recorded for 1.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Ibandronate Sodium: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/ibandronate-sodium

Reading the evidence

  • 12 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    8 of the 11 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 10 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (12)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Ibandronate Sodium. Country is the organisation's recorded country, not necessarily the manufacturing site.

India8Canada1Poland1Argentina1Country not recorded for 1
Need Ibandronate Sodium sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (3)

Certificates of Suitability on the EDQM register for Ibandronate Sodium, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 4 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
FLEMING LABORATORIES LIMITED HyderabadIN
CEP 2022-338 - Rev 01
Ibandronate sodium monohydrate
Jun 2026—
MAPRIMED S.A. Buenos AiresAR
CEP 2025-243 - Rev 00
Ibandronate sodium monohydrate
Feb 2026Inspected Jul 2025
France
PHARMACEUTICAL WORKS POLPHARMA S.A. Starogard GdanskiPL
R0-CEP 2023-077 - Rev 00
Ibandronate sodium monohydrate, Type I
Jun 2023—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (2)

Organisations whose Type II DMFs for Ibandronate Sodium are no longer active. These show a past filing, not current supply.

Show all 2 historical records
  • Teva Pharmaceutical Industries Ltd.
    Israel · Inactive DMF 20494 · filed Apr 2007
  • Italy · Inactive DMF 20427 · filed Apr 2007

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Ibandronate Sodium is a bisphosphonate class drug used to prevent and treat osteoporosis in postmenopausal women. It works by inhibiting osteoclast-mediated bone resorption, thus increasing bone mineral density.

Chemical identity

IUPAC name
sodium;hydroxy-[1-hydroxy-3-[methyl(pentyl)amino]-1-phosphonopropyl]phosphinate;hydrate
Canonical SMILES
CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)[O-].O.[Na+]
InChIKey
VBDRTGFACFYFCT-UHFFFAOYSA-M
Synonyms
Boniva API, bm-21.0955, bm-210955, boniva, dp-r206 component ibandronate, ibandronate sodium hydrate, ibandronate sodium monohydrate, ibandronic acid (as sodium ibandronate), ibandronic acid sodium salt, ibandronic acid sodium salt monohydrate, ibandronic sodium monohydrate, ibandronate monosodium monohydrate

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Bisphosphonate
Chemical structure
Diphosphonates

Therapeutic areas

OsteoporosisBone Disorders

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Ibandronate Sodium?

12 organisations hold an active US FDA Type II Drug Master File or a CEP for Ibandronate Sodium: Dr. Reddy's Laboratories Ltd. (India), Natco Pharma (India), APITORIA PHARMA PRIVATE LTD (India), Apotex Inc. (Canada), Emcure Pharmaceuticals Limited (India), Macleods Pharmaceuticals Ltd. (India), ORBION PHARMACEUTICALS PRIVATE LTD (India) and Sun Pharmaceutical Industries Limited (India), and 4 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Ibandronate Sodium Drug Master Files are active?

Dr. Reddy's Laboratories Ltd. (DMF 20466, 22300), Natco Pharma (DMF 24824, 20411), APITORIA PHARMA PRIVATE LTD (DMF 20393), Apotex Inc. (DMF 20525), Emcure Pharmaceuticals Limited (DMF 25172), Macleods Pharmaceuticals Ltd. (DMF 25793), ORBION PHARMACEUTICALS PRIVATE LTD (DMF 20422) and Sun Pharmaceutical Industries Limited (DMF 20605) and 1 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Ibandronate Sodium records mean?

2 organisations have only inactive Type II DMFs for Ibandronate Sodium. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Ibandronate Sodium have a European Certificate of Suitability?

Yes. 3 organisations hold a valid CEP for Ibandronate Sodium on the EDQM register, including FLEMING LABORATORIES LIMITED Hyderabad (IN), MAPRIMED S.A. Buenos Aires (AR) and PHARMACEUTICAL WORKS POLPHARMA S.A. Starogard Gdanski (PL). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Ibandronate Sodium supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Ibandronate Sodium?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.